Literature DB >> 19754820

Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expression.

R Uyama1, T Nakagawa, S-H Hong, M Mochizuki, R Nishimura, N Sasaki.   

Abstract

Four new pairs of canine mammary carcinoma cell lines derived from both primary and metastatic lesions were established. The cells were cultured in RPMI-1640 with 10% fetal bovine serum and they showed stable growth for more than 120 passages. Using these cell lines, the expression of E-cadherin was measured by flow cytometry and the function of E-cadherin was evaluated by cell aggregation assay and results from the primary and metastatic lesions were compared statistically. E-cadherin was strongly expressed in all of the cell lines, without a notable difference between cells of primary and metastatic origin. In the cell aggregation assay, the function of E-cadherin was significantly weaker in the cells of primary origin (p < 0.05), as compared with cells of metastatic origin. The present results suggest that a reduction in E-cadherin function may be implicated in the invasive and metastatic potential of canine mammary tumour cells; however, further study will be needed to clarify E-cadherin function in the context of the metastasis of canine mammary carcinoma.

Entities:  

Year:  2006        PMID: 19754820     DOI: 10.1111/j.1476-5810.2006.00098.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  22 in total

1.  Salinomycin inhibits canine mammary carcinoma in vitro by targeting cancer stem cells.

Authors:  Hongchao Du; Bin Zhou; Hong Zhang; Yipeng Jin; Di Zhang; Degui Lin
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

2.  Use of a colorimetric assay to evaluate the proliferation of canine mammary tumor cells exposed to propofol.

Authors:  Martina Argano; Raffaella De Maria; Katrin Rodlsberger; Paolo Buracco; M Paula Larenza Menzies
Journal:  Can J Vet Res       Date:  2019-04       Impact factor: 1.310

3.  NGS-identified miRNAs in Canine Mammary Gland Tumors Show Unexpected Expression Alterations in qPCR Analysis.

Authors:  Hui-Wen Chen; Yu-Chang Lai; Md Mahfuzur Rahman; Al Asmaul Husna; Md Nazmul Hasan; Hitoshi Hatai; Noriaki Miyoshi; Osamu Yamato; Naoki Miura
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

4.  High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression.

Authors:  Elpetra P M Timmermans-Sprang; Ana Gracanin; Jan A Mol
Journal:  BMC Cancer       Date:  2015-07-25       Impact factor: 4.430

5.  Apoptosis inhibitor of macrophage (AIM) reduces cell number in canine histiocytic sarcoma cell lines.

Authors:  Mona Uchida; Kohei Saeki; Shingo Maeda; Satoshi Tamahara; Tomohiro Yonezawa; Naoaki Matsuki
Journal:  J Vet Med Sci       Date:  2016-05-30       Impact factor: 1.267

6.  The role of SET/I2PP2A in canine mammary tumors.

Authors:  Satoru Kake; Shunya Tsuji; Shuhei Enjoji; Sayaka Hanasaki; Hiroshi Hayase; Ryotaro Yabe; Yuiko Tanaka; Takayuki Nakagawa; Hao-Ping Liu; Shih-Chieh Chang; Tatsuya Usui; Takashi Ohama; Koichi Sato
Journal:  Sci Rep       Date:  2017-06-27       Impact factor: 4.379

7.  5-Azacytidine treatment induces demethylation of DAPK1 and MGMT genes and inhibits growth in canine mammary gland tumor cells.

Authors:  Xiaoli Ren; Huatao Li; Xianyi Song; Yuhong Wu; Yun Liu
Journal:  Onco Targets Ther       Date:  2018-05-15       Impact factor: 4.147

8.  Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression.

Authors:  Ana Gracanin; Elpetra P M Timmermans-Sprang; Monique E van Wolferen; Nagesha A S Rao; Juraj Grizelj; Silvijo Vince; Eva Hellmen; Jan A Mol
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

9.  Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27.

Authors:  Tülay Bakirel; Fulya Üstün Alkan; Oya Üstüner; Suzan Çinar; Funda Yildirim; Gaye Erten; Utku Bakirel
Journal:  J Vet Med Sci       Date:  2016-01-29       Impact factor: 1.267

10.  Development of new therapy for canine mammary cancer with recombinant measles virus.

Authors:  Koichiro Shoji; Misako Yoneda; Tomoko Fujiyuki; Yosuke Amagai; Akane Tanaka; Akira Matsuda; Kikumi Ogihara; Yuko Naya; Fusako Ikeda; Hiroshi Matsuda; Hiroki Sato; Chieko Kai
Journal:  Mol Ther Oncolytics       Date:  2016-01-13       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.